What the business is, and whether it's a good one at a fair price.
Rebranded from Kapil Cotex Limited to Skybiotech Healthcare Limited effective 7 November 2025, with its Corporate Identification Number reclassified from L17100 (textiles) to L21001 (pharmaceuticals and healthcare), reflecting a stated pivot into healthcare. On a standalone basis, the original textile business is effectively dormant: standalone revenue from operations was just Rs 1.54 lakh in Q2 FY26 and zero in Q3 FY26. The actual activity sits in subsidiary Skybiotech Life Sciences Pvt Ltd, which contributed Rs 733.69 lakh of income but a loss of Rs 105.72 lakh in FY26. Consolidated FY26 revenue from operations was Rs 709.78 lakh (up 0.65% YoY), with a consolidated net loss of Rs 111.68 lakh, narrower than the Rs 236.89 lakh loss in FY25. Quarterly trends are choppy — consolidated Q2 FY26 revenue of Rs 191.65 lakh collapsed to Rs 96.27 lakh in Q3 FY26. Materials make up 43.6% of revenue, employees 24.8%, and other operating expenses 40.8%.
Measured from the filed financials, judged against its Other Textile Products peers · as of FY26 — not investment advice
How has the market priced it — with filings on the timeline?
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
How does it stack up on valuation, returns and growth?
Loading peers…
Quarterly & annual P&L, balance sheet, cash flow, ratios and segments.
Loading financials…
Who owns it — and is the promoter stake clean?
Loading shareholding…
Sign up to see the full company file
Governance, sustainability, compliance, earnings calls, presentations, events, reactions and the full filings feed — free with an account.
Answered from SKYBIOTECH HEALTHCARE LIMITED's filed financials and exchange disclosures
SKYBIOTECH HEALTHCARE LIMITED is a Textiles & Apparels company listed on BSE.
No. Over the trailing twelve months SKYBIOTECH HEALTHCARE LIMITED reported a net loss of ₹1 Cr on revenue of ₹7 Cr.
Not in the latest reported year — SKYBIOTECH HEALTHCARE LIMITED's dividend payout for FY26 was nil.
No. Debt stands at 0.91× equity, and it carries net debt of ₹9 Cr. That is lower than 23% of its 214 Other Textile Products peers.
On trailing P/E, SKYBIOTECH HEALTHCARE LIMITED ranks 126 of 205 in Other Textile Products — cheaper than 39% of them, against an industry median of 14.8×. This is a position, not a valuation judgement.
On a typical session SKYBIOTECH HEALTHCARE LIMITED moves 4.53% — that is the median absolute close-to-close move across its last 163 trading days. Announcement days are routinely larger.
Every NSE and BSE filing by SKYBIOTECH HEALTHCARE LIMITED appears on this page, AI-summarised, alongside the price reaction that followed it. Follow the company to get each new filing on WhatsApp within minutes.
Figures are as last reported and may lag the latest filing. Not investment advice.
